Published in Rev Neurol (Paris) on December 01, 1998
Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog (2010) 1.89
Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. AJNR Am J Neuroradiol (2004) 1.78
Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience (2001) 1.63
Viral parkinsonism. Biochim Biophys Acta (2008) 1.57
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol (2009) 1.57
HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia (2006) 1.53
Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol (2005) 1.42
Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. Am J Pathol (2004) 1.40
Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder. J Magn Reson Imaging (2010) 1.35
Monocyte/macrophages and their role in HIV neuropathogenesis. Immunol Rev (2013) 1.31
Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J Virol (2004) 1.24
Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol (2012) 1.23
MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis. J Virol (2004) 1.17
Molecular targets of opiate drug abuse in neuroAIDS. Neurotox Res (2005) 1.16
Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration. J Immunol (2009) 1.14
Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders. PLoS Pathog (2011) 1.14
Disease burden in HIV-associated cognitive impairment: a study of whole-brain imaging measures. Neurology (2004) 1.13
Nonhuman primate models of NeuroAIDS. J Neurovirol (2008) 1.07
Platelet-derived growth factor protects neurons against gp120-mediated toxicity. J Neurovirol (2008) 1.07
Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects. J Virol (2008) 1.02
Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. Am J Pathol (2004) 1.00
Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol (2006) 0.99
Mechanisms of HIV-tat-induced phosphorylation of N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for neuroAIDS pathogenesis. Am J Pathol (2010) 0.98
Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms. Curr HIV Res (2012) 0.93
Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD). Mol Neurodegener (2011) 0.92
Patterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study. J Neurovirol (2012) 0.92
HIV neuropathogenesis: a tight rope walk of innate immunity. J Neuroimmune Pharmacol (2010) 0.92
Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue. Retrovirology (2012) 0.91
HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1. J Immunol (2011) 0.90
SIV encephalitis lesions are composed of CD163(+) macrophages present in the central nervous system during early SIV infection and SIV-positive macrophages recruited terminally with AIDS. Am J Pathol (2015) 0.87
HIV-1 Nef in macrophage-mediated disease pathogenesis. Int Rev Immunol (2012) 0.86
HIV stroke risk: evidence and implications. Ther Adv Chronic Dis (2013) 0.86
Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis. Future Virol (2010) 0.86
Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta. PLoS One (2012) 0.86
Neuronal toxicity in HIV CNS disease. Future Virol (2012) 0.85
Microglia activation by SIV-infected macrophages: alterations in morphology and cytokine secretion. J Neurovirol (2012) 0.84
PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium. Toxicol Appl Pharmacol (2009) 0.84
HIV-1 gp120-induced axonal injury detected by accumulation of β-amyloid precursor protein in adult rat corpus callosum. J Neuroimmune Pharmacol (2011) 0.83
Image evaluation of HIV encephalopathy: a multimodal approach using quantitative MR techniques. Neuroradiology (2011) 0.83
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. J Neuropsychiatry Clin Neurosci (2011) 0.81
Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors. Int Rev Neurobiol (2014) 0.81
HIV-associated neuropathogenesis: a systems biology perspective for modeling and therapy. Biosystems (2014) 0.80
Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection. J Neurovirol (2011) 0.80
N-methyl-D-aspartate receptor-mediated axonal injury in adult rat corpus callosum. J Neurosci Res (2012) 0.79
Gene expression profiles and protein-protein interaction network analysis in AIDS patients with HIV-associated encephalitis and dementia. HIV AIDS (Auckl) (2015) 0.78
The retrovirus/superantigen hypothesis of multiple sclerosis. Cell Mol Neurobiol (2014) 0.77
Strain-specific viral distribution and neuropathology of feline immunodeficiency virus. Vet Immunol Immunopathol (2011) 0.77
Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages. J Drug Deliv (2016) 0.76
Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia. Curr HIV Res (2016) 0.76
Neural correlates of working memory training in HIV patients: study protocol for a randomized controlled trial. Trials (2016) 0.76
Mouse hepatitis virus infection upregulates genes involved in innate immune responses. PLoS One (2014) 0.75
Aspartoacylase deficiency in the white matter of human immunodeficiency virus encephalitis: novel mechanism in axonal damage. Patholog Res Int (2011) 0.75